{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:39:14Z","timestamp":1792697954674,"version":"4.5.0"},"reference-count":237,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Clobenpropit is a histamine H3 receptor antagonist and has developed as a potential therapeutic drug due to its ability to inhibit CXCR4, a chemokine receptor involved in autoimmune diseases and cancer pathogenesis. The CXCL12\/CXCR4 axis involves several biological phenomena, including cell proliferation, migration, angiogenesis, inflammation, and metastasis. Accordingly, inhibiting CXCR4 can have promising clinical outcomes in patients with malignancy or autoimmune disorders. Based on available knowledge, Clobenpropit can effectively regulate the release of monocyte-derived inflammatory cytokine in autoimmune diseases such as juvenile idiopathic arthritis (JIA), presenting a potential targeted target with possible advantages over current therapeutic approaches. This review summarizes the intricate interplay between Clobenpropit and CXCR4 and the molecular mechanisms underlying their interactions, comprehensively analyzing their impact on immune regulation. Furthermore, we discuss preclinical and clinical investigations highlighting the probable efficacy of Clobenpropit for managing autoimmune diseases and cancer. Through this study, we aim to clarify the immunomodulatory role of Clobenpropit and its advantages and disadvantages as a novel therapeutic opportunity.<\/jats:p>","DOI":"10.3389\/fphar.2024.1410104","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T04:29:09Z","timestamp":1720758549000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["The story of clobenpropit and CXCR4: can be an effective drug in cancer and autoimmune diseases?"],"prefix":"10.3389","volume":"15","author":[{"given":"Mitra","family":"Abbasifard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kowsar","family":"Bagherzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Khorramdelazad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.18502\/ijaai.v20i1.5418","article-title":"Higher circulating concentration of Interleukin-38 in patients with knee osteoarthritis: its association with disease severity","volume":"20","author":"Abassifard","year":"2021","journal-title":"Iran. J. Allergy, Asthma Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12879-023-08225-9","article-title":"Evaluation of the interaction between tumor growth factor-\u03b2 and interferon type I pathways in patients with COVID-19: focusing on ages 1 to 90 years","volume":"23","author":"Abbasifard","year":"2023","journal-title":"BMC Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12865-020-00388-3","article-title":"Assessing the expression of immunosuppressive cytokines in the newly diagnosed systemic lupus Erythematosus patients: a focus on B cells","volume":"21","author":"Abbasifard","year":"2020","journal-title":"Bmc Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/jocd.12994","article-title":"Evaluation of the expression of the stromal cell\u2010derived factor\u20101 alpha (CXCL 12) in psoriatic patients after treatment with Methotrexate","volume":"19","author":"Abdelaal","year":"2020","journal-title":"J. Cosmet. Dermatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1365-3083.2007.01938.x","article-title":"Histamine in rheumatoid arthritis","volume":"65","author":"Adlesic","year":"2007","journal-title":"Scand. J. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/s0960-9822(00)00380-8","article-title":"Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation","volume":"10","author":"Agace","year":"2000","journal-title":"Curr. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1600-0897.2012.01167.x","article-title":"Differential expression of CXC chemokines CXCL 10 and CXCL 12 in term and pre\u2010term neonates and their mothers","volume":"68","author":"Aminzadeh","year":"2012","journal-title":"Am. J. Reproductive Immunol."},{"key":"B8","volume-title":"An emerging paradigm of CXCL12 involvement in the metastatic cascade","author":"Anastasiadou","year":"2023"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1182\/blood-2004-07-2563","article-title":"The role of CXCL12 in the organ-specific process of artery formation","volume":"105","author":"Ara","year":"2005","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s1074-7613(03)00201-2","article-title":"Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny","volume":"19","author":"Ara","year":"2003","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1158\/0008-5472.CAN-08-2819","article-title":"Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer","volume":"69","author":"Arumugam","year":"2009","journal-title":"Cancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.17179\/excli2014-585","article-title":"Homing in hematopoietic stem cells: focus on regulatory role of CXCR7 on SDF1a\/CXCR4 axis","volume":"15","author":"Asri","year":"2016","journal-title":"EXCLI J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s12031-011-9672-6","article-title":"The SDF-1 3\u2032 a genetic variation of the chemokine SDF-1\u03b1 (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients","volume":"47","author":"Azin","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0125340","DOI":"10.1371\/journal.pone.0125340","article-title":"Infection of female BWF1 lupus mice with malaria parasite attenuates B cell autoreactivity by modulating the CXCL12\/CXCR4 axis and its downstream signals PI3K\/AKT, NF\u03baB and ERK","volume":"10","author":"Badr","year":"2015","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000494435","article-title":"CXCL12 and CXCR4 in the peripheral blood of patients with Parkinson\u2019s disease","volume":"25","author":"Bagheri","year":"2019","journal-title":"Neuroimmunomodulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1242\/dev.129.18.4249","article-title":"The chemokine SDF1 regulates migration of dentate granule cells","volume":"129","author":"Bagri","year":"2002","journal-title":"Development"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.4049\/jimmunol.170.6.3392","article-title":"Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus","volume":"170","author":"Balabanian","year":"2003","journal-title":"J. Immunol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1101\/2021.10.24.465080","article-title":"Targeting the chemokine receptor CXCR4 with histamine analogue to reduce inflammation in juvenile arthritis: a proof of concept for COVID-19 therapeutic approach","author":"Bekaddour","year":"2021","journal-title":"bioRxiv"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1178172","DOI":"10.3389\/fimmu.2023.1178172","article-title":"Targeting the chemokine receptor CXCR4 with histamine analog to reduce inflammation in juvenile arthritis","volume":"14","author":"Bekaddour","year":"2023","journal-title":"Front. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/1479-5876-10-251","article-title":"Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic lupus erythematosus","volume":"10","author":"Biajoux","year":"2012","journal-title":"J. Transl. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"28960","DOI":"10.1073\/pnas.2013644117","article-title":"CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response","volume":"117","author":"Biasci","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41591-020-0880-x","article-title":"BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial","volume":"26","author":"Bockorny","year":"2020","journal-title":"Nat. Med."},{"key":"B23","volume-title":"Development of CXCR4 inhibitors for topical treatment of psoriasis","author":"Boonsith","year":"2017"},{"key":"B24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1365-2141.2007.06590.x","article-title":"The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target","volume":"137","author":"Burger","year":"2007","journal-title":"Br. J. Haematol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3109\/08830185.2012.697230","article-title":"Genetic basis of altered central tolerance and autoimmune diseases: a lesson from AIRE mutations","volume":"31","author":"Capalbo","year":"2012","journal-title":"Int. Rev. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"11068","DOI":"10.1073\/pnas.1006375107","article-title":"Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis","volume":"107","author":"Carbajal","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4161\/cbt.9.1.10342","article-title":"CXCL12\/CXCR4 promotes motility and proliferation of glioma cells","volume":"9","author":"Carmo","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1177\/1087057114526283","article-title":"CXCR4 antagonists: a screening strategy for identification of functionally selective ligands","volume":"19","author":"Castaldo","year":"2014","journal-title":"J. Biomol. Screen."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1523\/JNEUROSCI.23-04-01360.2003","article-title":"A chemokine, SDF-1, reduces the effectiveness of multiple axonal repellents and is required for normal axon pathfinding","volume":"23","author":"Chalasani","year":"2003","journal-title":"J. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/B978-0-12-411638-2.00002-1","article-title":"The intricate role of CXCR4 in cancer","volume":"124","author":"Chatterjee","year":"2014","journal-title":"Adv. cancer Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ijrobp.2021.03.031","article-title":"The oral CXCR4 inhibitor X4-136 improves tumor control and reduces toxicity in cervical cancer treated with radiation therapy and concurrent chemotherapy","volume":"110","author":"Chaudary","year":"2021","journal-title":"Int. J. Radiat. Oncology* Biology* Phys."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00011-007-0638-7","article-title":"The European histamine research society (EHRS) symposium for EPHAR 2008","volume":"57","author":"Chazot","year":"2008","journal-title":"Inflamm. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.cyto.2014.06.007","article-title":"The role of CXCL12 and CCL7 chemokines in immune regulation, embryonic development, and tissue regeneration","volume":"69","author":"Cheng","year":"2014","journal-title":"Cytokine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1517\/14728220903196761","article-title":"Targeting the CXCR4\/CXCL12 axis in systemic lupus erythematosus","volume":"13","author":"Chong","year":"2009","journal-title":"Expert Opin. Ther. targets"},{"key":"B35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/s0925-4773(01)00520-2","article-title":"Expression pattern of two zebrafish genes, cxcr4a and cxcr4b","volume":"109","author":"Chong","year":"2001","journal-title":"Mech. Dev."},{"key":"B36","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2013.12.007","article-title":"The role of reactive oxygen species and metabolism on cancer cells and their microenvironment","volume-title":"Seminars in cancer biology","author":"Costa","year":"2014"},{"key":"B37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/PL00000188","article-title":"Human pancreatic carcinoma cell line Panc-I and the role of histamine in growth regulation","volume":"49","author":"Cricco","year":"2000","journal-title":"Inflamm. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1007\/s00011-003-0331-4","article-title":"Histamine regulates the MAPK pathway via the H 2 receptor in PANC-1 human cells","volume":"53","author":"Cricco","year":"2004","journal-title":"Inflamm. Res."},{"key":"B39","first-page":"4443","article-title":"Histamine inhibits cell proliferation and modulates the expression of Bcl-2 family proteins via the H2 receptor in human pancreatic cancer cells","volume":"26","author":"Cricco","year":"2006","journal-title":"Anticancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00011-007-0611-5","article-title":"Histamine regulates pancreatic carcinoma cell growth through H3 and H4 receptors","volume":"57","author":"Cricco","year":"2008","journal-title":"Inflamm. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0092-8674(91)90638-f","article-title":"Growth factors in development, transformation, and tumorigenesis","volume":"64","author":"Cross","year":"1991","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.3390\/cancers12071952","article-title":"New CXCR4 antagonist peptide R (Pep R) improves standard therapy in colorectal cancer","volume":"12","author":"D'Alterio","year":"2020","journal-title":"Cancers"},{"key":"B43","doi-asserted-by":"publisher","first-page":"7907","DOI":"10.4049\/jimmunol.179.11.7907","article-title":"Functional expression of H4 histamine receptor in human natural killer cells, monocytes, and dendritic cells","volume":"179","author":"Damaj","year":"2007","journal-title":"J. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"173936","DOI":"10.1016\/j.ejphar.2021.173936","article-title":"CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2\/4 inhibitors in glioblastoma multiforme","volume":"897","author":"Daniele","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s43440-019-00002-3","article-title":"The inhibitory effect of Ph\u03b11\u03b2 toxin on diabetic neuropathic pain involves the CXCR4 chemokine receptor","volume":"72","author":"da Silva Junior","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7150\/thno.5376","article-title":"Small molecule inhibitors of CXCR4","volume":"3","author":"Debnath","year":"2013","journal-title":"Theranostics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrd1134","article-title":"The bicyclam AMD3100 story","volume":"2","author":"De Clercq","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2040206619829382","DOI":"10.1177\/2040206619829382","article-title":"Mozobil\u00ae (plerixafor, AMD3100), 10 years after its approval by the US food and drug administration","volume":"27","author":"De Clercq","year":"2019","journal-title":"Antivir. Chem. Chemother."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e370","DOI":"10.1016\/S1470-2045(18)30480-7","article-title":"CXCR4-targeted therapy in breast cancer","volume":"19","author":"Derlin","year":"2018","journal-title":"lancet Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3389\/fimmu.2020.01683","article-title":"Systems biology approaches to understanding the human immune system","volume":"11","author":"Dhillon","year":"2020","journal-title":"Front. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jaci.2007.03.024","article-title":"Histamine downregulates monocyte CCL2 production through the histamine H4 receptor","volume":"120","author":"Dijkstra","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.7150\/jca.72331","article-title":"Regulation of tumor and metastasis initiation by chemokine receptors","volume":"13","author":"DiNatale","year":"2022","journal-title":"J. Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3649330\/v1","article-title":"Low dose methotrexate impaired T cell transmigration through down-regulating CXCR4 expression in rheumatoid arthritis","author":"Ding","year":"2023","journal-title":"Research Article"},{"key":"B54","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature11885","article-title":"Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches","volume":"495","author":"Ding","year":"2013","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1593\/neo.12324","article-title":"CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy","volume":"14","author":"Domanska","year":"2012","journal-title":"Neoplasia"},{"key":"B56","doi-asserted-by":"publisher","first-page":"806741","DOI":"10.1155\/2014\/806741","article-title":"Chemokines referee inflammation within the central nervous system during infection and disease","volume":"2014","author":"Durrant","year":"2014","journal-title":"Adv. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cytogfr.2004.06.003","article-title":"Histamine\u2013cytokine connection in immunity and hematopoiesis","volume":"15","author":"Dy","year":"2004","journal-title":"Cytokine & growth factor Rev."},{"key":"B58","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/ITT.S243636","article-title":"Role of chemokines and chemokine receptors in rheumatoid arthritis","volume":"9","author":"Elemam","year":"2020","journal-title":"ImmunoTargets Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1124\/jpet.102.047183","article-title":"Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. in vitro pharmacological effects","volume":"305","author":"Esbenshade","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B60","doi-asserted-by":"publisher","first-page":"102391","DOI":"10.1016\/j.autrev.2019.102391","article-title":"MicroRNAs in rheumatoid arthritis: from pathogenesis to clinical impact","volume":"18","author":"Evangelatos","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"dgz289","DOI":"10.1210\/clinem\/dgz289","article-title":"Th1 chemokines in autoimmune endocrine disorders","volume":"105","author":"Fallahi","year":"2020","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-11-195","article-title":"Attenuated expression of HRH4 in colorectal carcinomas: a potential influence on tumor growth and progression","volume":"11","author":"Fang","year":"2011","journal-title":"BMC cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3892\/etm.2021.9890","article-title":"microRNA-23 inhibits inflammation to alleviate rheumatoid arthritis via regulating CXCL12","volume":"21","author":"Gao","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"115622","DOI":"10.1016\/j.biopha.2023.115622","article-title":"Microenvironmental regulation in tumor progression: interactions between cancer-associated fibroblasts and immune cells","volume":"167","author":"Gao","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B65","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3389\/fendo.2019.00585","article-title":"The role of the CXCL12\/CXCR4\/ACKR3 axis in autoimmune diseases","volume":"10","author":"Garc\u00eda-Cuesta","year":"2019","journal-title":"Front. Endocrinol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2174\/138955710793564124","article-title":"Histamine H4 receptor: a novel therapeutic target for immune and allergic responses","volume":"10","author":"Bhatt","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"175586","DOI":"10.1016\/j.ejphar.2023.175586","article-title":"The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF","volume":"949","author":"Ghalehbandi","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/jcp.10445","article-title":"CXCL12 chemokine up\u2010regulates bone resorption and MMP\u20109 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients","volume":"199","author":"Grassi","year":"2004","journal-title":"J. Cell. physiology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature11926","article-title":"CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance","volume":"495","author":"Greenbaum","year":"2013","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00011-007-0631-1","article-title":"Expression of histamine H4 receptor in human osteoarthritic synovial tissue","volume":"57","author":"Grzybowska-Kowalczyk","year":"2008","journal-title":"Inflamm. Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1007\/s00011-006-0529-3","article-title":"Human and clinical aspects of histamine: distribution pattern of histamine H 4 receptor in human synovial tissue from patients with rheumatoid arthritis","volume":"56","author":"Grzybowska-Kowalczyk","year":"2007","journal-title":"Inflamm. Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/jid.2011.72","article-title":"The histamine H4 receptor is highly expressed on plasmacytoid dendritic cells in psoriasis and histamine regulates their cytokine production and migration","volume":"131","author":"Gschwandtner","year":"2011","journal-title":"J. investigative dermatology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1515\/cclm-2012-0653","article-title":"Psoriasis, a new challenge for laboratory medicine","volume":"51","author":"Gulletta","year":"2013","journal-title":"Clin. Chem. Laboratory Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/978-1-4614-7876-8_17","article-title":"Mechanisms of metastasis","author":"Ha","year":"2013","journal-title":"Cancer Target. Drug Deliv. Elus. Dream"},{"key":"B76","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fonc.2020.00221","article-title":"Resistance mechanisms to anti-angiogenic therapies in cancer","volume":"10","author":"Haibe","year":"2020","journal-title":"Front. Oncol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.apsb.2020.12.005","article-title":"An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation","volume":"11","author":"Harms","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"B78","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.arcmed.2010.07.001","article-title":"Assessment of CXCL12 (SDF-1\u03b1) polymorphisms and its serum level in posttransfusion occult HBV-infected patients in Southeastern Iran","volume":"41","author":"Hassanshahi","year":"2010","journal-title":"Archives Med. Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clim.2006.09.016","article-title":"HIV-1 immunopathogenesis: how good interferon turns bad","volume":"123","author":"Herbeuval","year":"2007","journal-title":"Clin. Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"154616","DOI":"10.1016\/j.prp.2023.154616","article-title":"The pathological role of CXC chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC) progression; special focus on molecular mechanisms and possible therapeutics","volume":"248","author":"Hjazi","year":"2023","journal-title":"Pathology-Research Pract."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1124\/jpet.102.046581","article-title":"Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells","volume":"305","author":"Hofstra","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/hep.22890","article-title":"Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation","volume":"49","author":"Hong","year":"2009","journal-title":"Hepatology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1756-9966-29-80","article-title":"Breast cancer stromal fibroblasts promote the generation of CD44+ CD24-cells through SDF-1\/CXCR4 interaction","volume":"29","author":"Huang","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"714169","DOI":"10.3389\/fcell.2021.714169","article-title":"Premyelinating oligodendrocytes: mechanisms underlying cell survival and integration","volume":"9","author":"Hughes","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/82_2010_74","article-title":"Hypoxia-inducible factors as essential regulators of inflammation","volume":"345","author":"Imtiyaz","year":"2010","journal-title":"Diverse Eff. Hypoxia Tumor Progression"},{"key":"B86","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.bbr.2007.11.001","article-title":"Comparison of the effect of an H3-inverse agonist on energy intake and hypothalamic histamine release in normal mice and leptin resistant mice with high fat diet-induced obesity","volume":"188","author":"Ishizuka","year":"2008","journal-title":"Behav. Brain Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/thno.5760","article-title":"CXCR4 chemokine receptor overview: biology, pathology and applications in imaging and therapy","volume":"3","author":"Jacobson","year":"2013","journal-title":"Theranostics"},{"key":"B88","first-page":"535","article-title":"Environmental triggers and epigenetic deregulation in autoimmune disease","volume":"12","author":"Javierre","year":"2011","journal-title":"Discov. Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12032-023-01953-7","article-title":"CAFs secrete CXCL12 to accelerate the progression and cisplatin resistance of colorectal cancer through promoting M2 polarization of macrophages","volume":"40","author":"Jiang","year":"2023","journal-title":"Med. Oncol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1111\/j.1442-2042.2007.01866.x","article-title":"Role of Wnt\/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha","volume":"14","author":"Jiang","year":"2007","journal-title":"Int. J. urology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"10455","DOI":"10.1073\/pnas.1710754114","article-title":"Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer","volume":"114","author":"Jung","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.3389\/fimmu.2018.01878","article-title":"Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: current limitations and future options","volume":"9","author":"Kabacaoglu","year":"2018","journal-title":"Front. Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1124\/mol.108.053389","article-title":"AMD3100 is a CXCR7 ligand with allosteric agonist properties","volume":"75","author":"Kalatskaya","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1399-0004.2011.01809.x","article-title":"Epigenetic modifications in cancer","volume":"81","author":"Kanwal","year":"2012","journal-title":"Clin. Genet."},{"key":"B95","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1111\/j.1572-0241.2000.03289.x","article-title":"Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease","volume":"95","author":"Katsuta","year":"2000","journal-title":"Am. J. gastroenterology"},{"key":"B96","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/cells8020185","article-title":"Involvement of CXCR4 in normal and abnormal development","volume":"8","author":"Kawaguchi","year":"2019","journal-title":"Cells"},{"key":"B97","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jneuroim.2015.11.021","article-title":"New insights into the role of stromal cell-derived factor 1 (SDF-1\/CXCL12) in the pathophysiology of multiple sclerosis","volume":"290","author":"Khorramdelazad","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2023.2256406","article-title":"Antitumor activities of a novel fluorinated small molecule (A1) in CT26 colorectal cancer cells: molecular docking and in vitro studies","author":"Khorramdelazad","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B99","doi-asserted-by":"publisher","first-page":"175051","DOI":"10.1016\/j.ejphar.2022.175051","article-title":"Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019","volume":"927","author":"Khorramdelazad","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nature01338","article-title":"A zebrafish homologue of the chemokine receptor Cxcr4 is a germ-cell guidance receptor","volume":"421","author":"Knaut","year":"2003","journal-title":"Nature"},{"key":"B101","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1182\/blood-2007-04-084210","article-title":"Development of plasmacytoid dendritic cells in bone marrow stromal cell niches requires CXCL12-CXCR4 chemokine signaling","volume":"110","author":"Kohara","year":"2007","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1750-3639.2008.00154.x","article-title":"Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis","volume":"18","author":"Kohler","year":"2008","journal-title":"Brain Pathol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"10922","DOI":"10.3390\/ijms222010922","article-title":"Cytokine networks in the pathogenesis of rheumatoid arthritis","volume":"22","author":"Kondo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B104","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/brain\/awh680","article-title":"Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment","volume":"129","author":"Krumbholz","year":"2006","journal-title":"Brain"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.3390\/cimb44070212","article-title":"The expression and prognostic significance of VEGF and CXCR4 in gastric cancer: correlation with Angiogenesis, Lymphangiogenesis and Progression","volume":"44","author":"Kruszyna","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1634\/stemcells.2004-0342","article-title":"Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1\u2013CXCR4 axis","volume":"23","author":"Kucia","year":"2005","journal-title":"Stem cells"},{"key":"B107","volume-title":"CXCR4 receptor expression and prostate cancer bone metastasis: role of stromal cell derived factor-1 alpha and nuclear factor kappa B","author":"Kukreja","year":"2005"},{"key":"B108","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.immuni.2006.06.015","article-title":"CXCR4 physically associates with the T cell receptor to signal in T cells","volume":"25","author":"Kumar","year":"2006","journal-title":"Immunity"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1155\/2021\/6655417","article-title":"Unraveling the molecular nexus between GPCRs, ERS, and EMT","volume":"2021","author":"Kumari","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"B110","doi-asserted-by":"publisher","first-page":"108084","DOI":"10.1016\/j.isci.2023.108084","article-title":"Excitable dynamics of flares and relapses in autoimmune diseases","volume":"26","author":"Lebel","year":"2023","journal-title":"Iscience"},{"key":"B111","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2174\/1381612820666140825122036","article-title":"Role of synovial fibroblasts in rheumatoid arthritis","volume":"21","author":"Lefevre","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"B112","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/kjm2.12540","article-title":"CXCR4 antagonist AMD3100 enhances therapeutic efficacy of transcatheter arterial chemoembolization in rats with hepatocellular carcinoma","volume":"38","author":"Lei","year":"2022","journal-title":"Kaohsiung J. Med. Sci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-2172-9-51","article-title":"Elevated CXCL12 expression in the bone marrow of NOD mice is associated with altered T cell and stem cell trafficking and diabetes development","volume":"9","author":"Leng","year":"2008","journal-title":"BMC Immunol."},{"key":"B114","first-page":"3812","article-title":"Suppression of chronic lymphocytic leukemia progression by CXCR4 inhibitor WZ811","volume":"8","author":"Li","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.devcel.2013.01.009","article-title":"Peripheral nerve-derived CXCL12 and VEGF-A regulate the patterning of arterial vessel branching in developing limb skin","volume":"24","author":"Li","year":"2013","journal-title":"Dev. Cell"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3892\/ijmm.2013.1521","article-title":"The role of the CXCL12-CXCR4\/CXCR7 axis in the progression and metastasis of bone sarcomas (Review)","volume":"32","author":"Liao","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.neuron.2005.08.011","article-title":"A Cxcl12-CXCR4 chemokine signaling pathway defines the initial trajectory of mammalian motor axons","volume":"47","author":"Lieberam","year":"2005","journal-title":"Neuron"},{"key":"B118","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.2174\/138161210794455003","article-title":"CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization","volume":"16","author":"Liekens","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar1918","article-title":"Interleukin-6 and rheumatic diseases","volume":"8","author":"Lipsky","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"B120","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jneuroim.2009.08.003","article-title":"Regulation of CXCL12 and CXCR4 expression by human brain endothelial cells and their role in CD4+ and CD8+ T cell adhesion and transendothelial migration","volume":"215","author":"Liu","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2019.01.032","article-title":"Drug delivery systems targeting tumor-associated fibroblasts for cancer immunotherapy","volume":"448","author":"Liu","year":"2019","journal-title":"Cancer Lett."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.23937\/2378-3419\/1410144","article-title":"CXCR4 antagonist AMD3100 (plerixafor) modulates immune responses in the tumor microenvironment","volume":"8","author":"Liu","year":"2021","journal-title":"Int. J. Cancer Clin. Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"105606","DOI":"10.1016\/j.ejps.2020.105606","article-title":"Targeting CXCL12-CXCR4 signaling enhances immune checkpoint blockade therapy against triple negative breast cancer","volume":"157","author":"Lu","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/med.22011","article-title":"CXCR4\/CXCL12 axis:\u201cold\u201d pathway as \u201cnovel\u201d target for anti-inflammatory drug discovery","volume":"44","author":"Lu","year":"2024","journal-title":"Med. Res. Rev."},{"key":"B125","doi-asserted-by":"publisher","first-page":"7090","DOI":"10.1073\/pnas.092013799","article-title":"Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor","volume":"99","author":"Lu","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B126","doi-asserted-by":"publisher","first-page":"9448","DOI":"10.1073\/pnas.95.16.9448","article-title":"Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4-and SDF-1-deficient mice","volume":"95","author":"Ma","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B127","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.clim.2011.12.008","article-title":"Alternative activation in systemic juvenile idiopathic arthritis monocytes","volume":"142","author":"Macaubas","year":"2012","journal-title":"Clin. Immunol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3390\/brainsci11121617","article-title":"Neuroprotective effect of clobenpropit against lipopolysaccharide-induced cognitive deficits via attenuating neuroinflammation and enhancing mitochondrial functions in mice","volume":"11","author":"Mani","year":"2021","journal-title":"Brain Sci."},{"key":"B129","doi-asserted-by":"publisher","first-page":"e1083","DOI":"10.1212\/NXI.0000000000001083","article-title":"CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis","volume":"8","author":"Marastoni","year":"2021","journal-title":"Neurology-Neuroimmunology Neuroinflammation"},{"key":"B130","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/pl00022452","article-title":"Histamine inhibits proliferation of a pancreatic carcinoma cell line without inducing apoptosis significantly","volume":"51","author":"Mart\u00edn","year":"2002","journal-title":"Inflamm. Res."},{"key":"B131","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s10753-022-01751-9","article-title":"Role of T cells in the pathogenesis of rheumatoid arthritis: focus on immunometabolism dysfunctions","volume":"46","author":"Masoumi","year":"2023","journal-title":"Inflammation"},{"key":"B132","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s10753-020-01371-1","article-title":"Destructive roles of fibroblast-like synoviocytes in chronic inflammation and joint damage in rheumatoid arthritis","volume":"44","author":"Masoumi","year":"2021","journal-title":"Inflammation"},{"key":"B133","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/bph.14535","article-title":"Histamine receptors and cancer pharmacology: an update","volume":"177","author":"Massari","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"8053","DOI":"10.4049\/jimmunol.177.11.8053","article-title":"CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis","volume":"177","author":"McCandless","year":"2006","journal-title":"J. Immunol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41584-019-0287-6","article-title":"Hitting the right spot on CXCR4","volume":"15","author":"McHugh","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4161\/cbt.7.1.5123","article-title":"The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment","volume":"7","author":"Medina","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"B137","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.pharep.2017.08.007","article-title":"Clobenpropit, a histamine H 3 receptor antagonist\/inverse agonist, inhibits [3 H]-dopamine uptake by human neuroblastoma SH-SY5Y cells and rat brain synaptosomes","volume":"70","author":"Mena-Avila","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/hep.24573","article-title":"The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis","volume":"54","author":"Meng","year":"2011","journal-title":"Hepatology"},{"key":"B139","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1124\/jpet.108.141085","article-title":"Blockade of CXCL12\/CXCR4 Axis ameliorates murine experimental colitis","volume":"327","author":"Mikami","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B140","doi-asserted-by":"publisher","first-page":"119034","DOI":"10.1016\/j.lfs.2021.119034","article-title":"Role of CCL2\/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: latest evidence and therapeutic approaches","volume":"269","author":"Moadab","year":"2021","journal-title":"Life Sci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"cm1","DOI":"10.1126\/stke.2712005cm1","article-title":"Wnt\/beta-catenin pathway","volume":"2005","author":"Moon","year":"2005","journal-title":"Science's STKE"},{"key":"B142","doi-asserted-by":"publisher","first-page":"117534","DOI":"10.1016\/j.lfs.2020.117534","article-title":"CXCL12\/CXCR4 axis in the microenvironment of solid tumors: a critical mediator of metastasis","volume":"249","author":"Mortezaee","year":"2020","journal-title":"Life Sci."},{"key":"B143","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.imlet.2019.11.007","article-title":"CXCL12\/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy","volume":"217","author":"Mousavi","year":"2020","journal-title":"Immunol. Lett."},{"key":"B144","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1007\/s11033-014-3335-y","article-title":"The role of polymorphisms of genes CXCL12\/CXCR4 and MIF in the risk development IBD the Polish population","volume":"41","author":"Mrowicki","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"B145","first-page":"1","volume-title":"Immune system disorders: hypersensitivity and autoimmunity. Immunoregulatory Aspects of Immunotherapy","author":"Mu\u00f1oz-Carrillo","year":""},{"key":"B146","first-page":"10","article-title":"Immune system disorders: hypersensitivity and autoimmunity","volume":"1","author":"Mu\u00f1oz-Carrillo","year":"","journal-title":"Immunoregul. Asp. Immunother."},{"key":"B147","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00109-014-1123-8","article-title":"CXC chemokine ligand 12 (CXCL12) and its receptor CXCR4","volume":"92","author":"Nagasawa","year":"2014","journal-title":"J. Mol. Med."},{"key":"B148","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/382635a0","article-title":"Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF\/SDF-1","volume":"382","author":"Nagasawa","year":"1996","journal-title":"Nature"},{"key":"B149","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.4049\/jimmunol.173.3.2078","article-title":"Liver-expressed chemokine\/CC chemokine ligand 16 attracts eosinophils by interacting with histamine H4 receptor","volume":"173","author":"Nakayama","year":"2004","journal-title":"J. Immunol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s10147-017-1187-x","article-title":"Biological\/pathological functions of the CXCL12\/CXCR4\/CXCR7 axes in the pathogenesis of bladder cancer","volume":"22","author":"Nazari","year":"2017","journal-title":"Int. J. Clin. Oncol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/cr.2007.69","article-title":"Regulation of hematopoiesis and the hematopoietic stem cell niche by Wnt signaling pathways","volume":"17","author":"Nemeth","year":"2007","journal-title":"Cell Res."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3390\/biom11081232","article-title":"Pathophysiological roles of histamine receptors in cancer progression: implications and perspectives as potential molecular targets","volume":"11","author":"Nguyen","year":"2021","journal-title":"Biomolecules"},{"key":"B153","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fphar.2019.00556","article-title":"Pathophysiological role of histamine H4 receptor in cancer: therapeutic implications","volume":"10","author":"Nicoud","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B154","first-page":"93","article-title":"Modifications: role in chemokine binding and receptor activation","volume-title":"Molecular insights into recognition, activation and function of the atypical chemokine receptor CXCR7\/ACKR3","author":"N terminus post-translational","year":"2016"},{"key":"B155","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1248\/bpb.30.2217","article-title":"Expression of histamine H4 receptor in synovial cells from rheumatoid arthritic patients","volume":"30","author":"Ohki","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1172\/JCI37028","article-title":"The diabetes gene Pdx1 regulates the transcriptional network of pancreatic endocrine progenitor cells in mice","volume":"119","author":"Oliver-Krasinski","year":"2009","journal-title":"J. Clin. investigation"},{"key":"B157","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1152\/ajpregu.00738.2001","article-title":"Chemokines and chemokine receptors in leukocyte trafficking","volume":"283","author":"Olson","year":"2002","journal-title":"Am. J. Physiology-Regulatory, Integr. Comp. Physiology"},{"key":"B158","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1586\/14737159.6.1.51","article-title":"Quantification of chemokines by real-time reverse transcriptase PCR: applications in type 1 diabetes","volume":"6","author":"Overbergh","year":"2006","journal-title":"Expert Rev. Mol. Diagnostics"},{"key":"B159","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/jnen\/62.6.593","article-title":"The blood-brain barrier and its role in immune privilege in the central nervous system","volume":"62","author":"Pachter","year":"2003","journal-title":"J. Neuropathology Exp. Neurology"},{"key":"B160","doi-asserted-by":"publisher","first-page":"8545","DOI":"10.3748\/wjg.v20.i26.8545","article-title":"Clobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer","volume":"20","author":"Paik","year":"2014","journal-title":"World J. Gastroenterology WJG"},{"key":"B161","doi-asserted-by":"publisher","first-page":"850998","DOI":"10.3389\/fimmu.2022.850998","article-title":"Role of the CXCL13\/CXCR5 axis in autoimmune diseases","volume":"13","author":"Pan","year":"2022","journal-title":"Front. Immunol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbcan.2006.06.004","article-title":"Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer","volume":"1775","author":"Pardali","year":"2007","journal-title":"Biochimica Biophysica Acta (BBA)-Reviews Cancer"},{"key":"B163","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s12035-017-0743-8","article-title":"Histamine H3 inverse agonist BF 2649 or antagonist with partial H4 agonist activity clobenpropit reduces amyloid beta peptide-induced brain pathology in Alzheimer\u2019s Disease","volume":"55","author":"Patnaik","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2121-15-15","article-title":"Intracellular trafficking and endocytosis of CXCR4 in fetal mesenchymal stem\/stromal cells","volume":"15","author":"Pelekanos","year":"2014","journal-title":"BMC Cell Biol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.3892\/etm.2020.8950","article-title":"Expression levels of CXCR4 and CXCL12 in patients with rheumatoid arthritis and its correlation with disease activity","volume":"20","author":"Peng","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"B166","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1357-4310(97)01077-0","article-title":"The blood-brain barrier and the inflammatory response","volume":"3","author":"Perry","year":"1997","journal-title":"Mol. Med. today"},{"key":"B167","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.it.2007.05.007","article-title":"The SDF-1\u2013CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis","volume":"28","author":"Petit","year":"2007","journal-title":"Trends Immunol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-3-030-62658-7_5","article-title":"CXCL12 signaling in the tumor microenvironment","volume":"1302","author":"Portella","year":"2021","journal-title":"Tumor Microenviron. Role Chemokines\u2013Part B"},{"key":"B170","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.imlet.2016.06.006","article-title":"CXCR4 signaling in health and disease","volume":"177","author":"Pozzobon","year":"2016","journal-title":"Immunol. Lett."},{"key":"B171","unstructured":"Clobenpropit (compound)\n          2024"},{"key":"B172","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12943-019-1091-2","article-title":"Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4","volume":"18","author":"Qin","year":"2019","journal-title":"Mol. cancer"},{"key":"B173","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/cancers13040645","article-title":"Focal adhesion kinase fine tunes multifaced signals toward breast cancer progression","volume":"13","author":"Rigiracciolo","year":"2021","journal-title":"Cancers"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.ajpath.2013.08.008","article-title":"Nature and mediators of parietal epithelial cell activation in glomerulonephritides of human and rat","volume":"183","author":"Rizzo","year":"2013","journal-title":"Am. J. pathology"},{"key":"B175","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/BOR.0b013e32835c7e32","article-title":"The interferon signature in autoimmune diseases","volume":"25","author":"R\u00f6nnblom","year":"2013","journal-title":"Curr. Opin. rheumatology"},{"key":"B176","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/08916930310001602128","article-title":"Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity","volume":"36","author":"R\u00f6nnblom","year":"2003","journal-title":"Autoimmunity"},{"key":"B177","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1365-3164.2009.00854.x","article-title":"The histamine H receptor as a new target for treatment of canine inflammatory skin diseases","volume":"20","author":"Ro\u00dfbach","year":"2009","journal-title":"Veterinary dermatol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/sj.mn.7800200","article-title":"Role of chemokines in angiogenesis: CXCL12\/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses","volume":"10","author":"Salcedo","year":"2003","journal-title":"Microcirculation"},{"key":"B179","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1158\/1078-0432.CCR-14-0914","article-title":"Molecular pathways: targeting the CXCR4\u2013CXCL12 axis\u2014untapped potential in the tumor microenvironment","volume":"21","author":"Scala","year":"2015","journal-title":"Clin. cancer Res."},{"key":"B180","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/MOG.0b013e328353e61e","article-title":"Inflammatory bowel disease pathogenesis: what is new?","volume":"28","author":"Scharl","year":"2012","journal-title":"Curr. Opin. gastroenterology"},{"key":"B181","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1002\/art.38539","article-title":"A118: laboratory investigation of the role of toll\u2010like receptors on kidney cells in pathogenesis of lupus nephritis","volume":"66","author":"Sen","year":"2014","journal-title":"Arthritis & Rheumatology"},{"key":"B182","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1189\/jlb.0612293","article-title":"The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications","volume":"93","author":"Shachar","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"B183","first-page":"12357","article-title":"Wnt\/\u03b2-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells","volume":"8","author":"Shan","year":"2015","journal-title":"Int. J. Clin. Exp. pathology"},{"key":"B184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pbr.2021.06.003","article-title":"Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy","volume":"266","author":"Sharma","year":"2021","journal-title":"Prog. Brain Res."},{"key":"B185","doi-asserted-by":"publisher","first-page":"574667","DOI":"10.3389\/fphar.2020.574667","article-title":"The role of the CXCL12\/CXCR4\/CXCR7 chemokine axis in cancer","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B186","unstructured":"AMD3100 side effects2024"},{"key":"B187","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1101\/gad.1813509","article-title":"Chemokine signaling guides regional patterning of the first embryonic artery","volume":"23","author":"Siekmann","year":"2009","journal-title":"Genes & Dev."},{"key":"B188","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bcp.2019.03.029","article-title":"The many facets of macrophages in rheumatoid arthritis","volume":"165","author":"Siouti","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"14253","DOI":"10.1038\/ncomms14253","article-title":"Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement","volume":"8","author":"Smith","year":"2017","journal-title":"Nat. Commun."},{"key":"B190","doi-asserted-by":"publisher","first-page":"eaav9019","DOI":"10.1126\/sciadv.aav9019","article-title":"Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement\u2014a new target for lupus treatment","volume":"5","author":"Smith","year":"2019","journal-title":"Sci. Adv."},{"key":"B191","doi-asserted-by":"publisher","first-page":"e2015433118","DOI":"10.1073\/pnas.2015433118","article-title":"A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment","volume":"118","author":"Song","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B192","doi-asserted-by":"publisher","first-page":"1066029","DOI":"10.3389\/fmolb.2022.1066029","article-title":"A role of salt bridges in mediating drug potency: a lesson from the N-myristoyltransferase inhibitors","volume":"9","author":"Spassov","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"B193","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1523\/JNEUROSCI.23-12-05123.2003","article-title":"CXCR4 regulates interneuron migration in the developing neocortex","volume":"23","author":"Stumm","year":"2003","journal-title":"J. Neurosci."},{"key":"B194","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/jid.2010.280","article-title":"Resolved psoriasis lesions retain expression of a subset of disease-related genes","volume":"131","author":"Su\u00e1rez-Fari\u00f1as","year":"2011","journal-title":"J. Investigative Dermatology"},{"key":"B195","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"key":"B196","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/31261","article-title":"The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract","volume":"393","author":"Tachibana","year":"1998","journal-title":"Nature"},{"key":"B197","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1038\/jid.2013.151","article-title":"CXCR4 negatively regulates keratinocyte proliferation in IL-23-mediated psoriasiform dermatitis","volume":"133","author":"Takekoshi","year":"2013","journal-title":"J. Investigative Dermatology"},{"key":"B198","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/cancers8020025","article-title":"Cimetidine and clobenpropit attenuate inflammation-associated colorectal carcinogenesis in male ICR mice","volume":"8","author":"Tanaka","year":"2016","journal-title":"Cancers"},{"key":"B199","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.1182\/blood-2010-03-272096","article-title":"Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients","volume":"116","author":"Tassone","year":"2010","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.biocel.2017.12.018","article-title":"The good and bad faces of the CXCR4 chemokine receptor","volume":"95","author":"Teixido","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"922111","DOI":"10.3389\/fimmu.2022.922111","article-title":"Two main cellular components in rheumatoid arthritis: communication between T cells and fibroblast-like synoviocytes in the joint synovium","volume":"13","author":"Tu","year":"2022","journal-title":"Front. Immunol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1182\/blood-2010-01-266833","article-title":"Loss of Cxcl12\/Sdf-1 in adult mice decreases the quiescent state of hematopoietic stem\/progenitor cells and alters the pattern of hematopoietic regeneration after myelosuppression","volume":"117","author":"Tzeng","year":"2011","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"B203","volume-title":"Characterisation of novel CXCR4-targeting nanobodies with anti-HIV and anti-tumoral activity","author":"Van Hout","year":"2019"},{"key":"B204","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jhep.2016.09.010","article-title":"Epithelial-mesenchymal transition in cholangiocarcinoma: from clinical evidence to regulatory networks","volume":"66","author":"Vaquero","year":"2017","journal-title":"J. hepatology"},{"key":"B205","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3389\/fimmu.2015.00403","article-title":"The importance of the CXCL12\/CXCR4 Axis in therapeutic approaches to diabetes mellitus attenuation","volume":"6","author":"Vidakovi\u0107","year":"2015","journal-title":"Front. Immunol."},{"key":"B206","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.3390\/ijms25105351","article-title":"Human and murine toll-like receptor-driven disease in systemic lupus erythematosus","volume":"25","author":"von Hofsten","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B207","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3748\/wjg.v20.i1.6","article-title":"Immunopathology of inflammatory bowel disease","volume":"20","author":"Wallace","year":"2014","journal-title":"World J. gastroenterology WJG"},{"key":"B208","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.4049\/jimmunol.0801920","article-title":"CXCR4\/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus","volume":"182","author":"Wang","year":"2009","journal-title":"J. Immunol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1002\/art.27685","article-title":"Dysregulated expression of CXCR4\/CXCL12 in subsets of patients with systemic lupus erythematosus","volume":"62","author":"Wang","year":"2010","journal-title":"Arthritis & Rheumatism"},{"key":"B210","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3892\/etm.2015.2748","article-title":"CXCR7 functions in colon cancer cell survival and migration","volume":"10","author":"Wang","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"B211","doi-asserted-by":"publisher","first-page":"927.e1","DOI":"10.1016\/j.joms.2015.12.018","article-title":"AMD3100 attenuates matrix metalloprotease-3 and -9 expressions and prevents cartilage degradation in a monosodium iodo-acetate\u2013induced rat model of temporomandibular osteoarthritis","volume":"74","author":"Wang","year":"2016","journal-title":"J. Oral Maxillofac. Surg."},{"key":"B212","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3389\/fonc.2019.01487","article-title":"Saikosaponin A inhibits triple-negative breast cancer growth and metastasis through downregulation of CXCR4","volume":"9","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"65","author":"Weening","year":"2004","journal-title":"Kidney Int."},{"key":"B214","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/gm277","article-title":"Stem cell approaches for diabetes: towards beta cell replacement","volume":"3","author":"Weir","year":"2011","journal-title":"Genome Med."},{"key":"B215","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7150\/thno.5135","article-title":"Involvement of CXCR4\/CXCR7\/CXCL12 interactions in inflammatory bowel disease","volume":"3","author":"Werner","year":"2013","journal-title":"Theranostics"},{"key":"B216","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/s1368-7646(02)00120-6","article-title":"Activation of the PI3K\/Akt pathway and chemotherapeutic resistance","volume":"5","author":"West","year":"2002","journal-title":"Drug Resist. Updat."},{"key":"B217","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1128\/AAC.00709-10","article-title":"Novel compounds containing multiple guanide groups that bind the HIV coreceptor CXCR4","volume":"55","author":"Wilkinson","year":"2011","journal-title":"Antimicrob. agents Chemother."},{"key":"B218","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.bone.2005.01.021","article-title":"Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts","volume":"36","author":"Wright","year":"2005","journal-title":"Bone"},{"key":"B219","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.lfs.2018.04.050","article-title":"CXCR4 overexpression is correlated with poor prognosis in colorectal cancer","volume":"208","author":"Xu","year":"2018","journal-title":"Life Sci."},{"key":"B220","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1039\/c3mb70120d","article-title":"Structural basis of the interactions between CXCR4 and CXCL12\/SDF-1 revealed by theoretical approaches","volume":"9","author":"Xu","year":"2013","journal-title":"Mol. Biosyst."},{"key":"B221","doi-asserted-by":"publisher","first-page":"898","DOI":"10.2310\/JIM.0b013e31825f9f69","article-title":"Association of CXCL12 levels in synovial fluid with the radiographic severity of knee osteoarthritis","volume":"60","author":"Xu","year":"2012","journal-title":"J. Investigative Med."},{"key":"B222","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.2174\/0929867326666191113113110","article-title":"The CXCL12-CXCR4 signaling axis plays a key role in cancer metastasis and is a potential target for developing novel therapeutics against metastatic cancer","volume":"27","author":"Yang","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"B223","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000063794","article-title":"Coordination of histamine H3 receptor antagonists with human adrenal cytochrome P450 enzymes","volume":"66","author":"Yang","year":"2002","journal-title":"Pharmacology"},{"key":"B224","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"B225","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.2337\/db07-0291","article-title":"Stromal cell derived factor-1 (SDF-1)\/CXCL12 attenuates diabetes in mice and promotes pancreatic beta-cell survival by activation of the prosurvival kinase Akt","volume":"56","author":"Yano","year":"2007","journal-title":"Diabetes"},{"key":"B226","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/bonekey.2013.34","article-title":"CXCL12\/CXCR4 signaling and other recruitment and homing pathways in fracture repair","volume":"2","author":"Yellowley","year":"2013","journal-title":"BoneKEy Rep."},{"key":"B227","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s13046-019-1319-4","article-title":"Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12\/CXCR4","volume":"38","author":"Yi","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B228","doi-asserted-by":"publisher","first-page":"9724","DOI":"10.1002\/jcb.28253","article-title":"CXCL12\/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K\/AKT signal pathway","volume":"120","author":"Yin","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"B229","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1359\/jbmr.2003.18.8.1404","article-title":"Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration","volume":"18","author":"Yu","year":"2003","journal-title":"J. bone mineral Res."},{"key":"B230","article-title":"Effect of the H (4) R antagonist JNJ7777120 on the cartilage histamine content in rats with adjuvant arthritis","volume-title":"Fundamental & clinical pharmacology","author":"Zampeli","year":"2008"},{"key":"B231","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1476-5381.2009.00151.x","article-title":"The role of histamine H4 receptor in immune and inflammatory disorders","volume":"157","author":"Zampeli","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B232","first-page":"1190","article-title":"MSX-122, an orally available small molecule targeting CXCR4, inhibits primary tumor growth in an orthotopic mouse model of lung cancer and improves the effect of paclitaxel","volume":"68","author":"Zhang","year":"2008","journal-title":"Cancer Res."},{"key":"B233","doi-asserted-by":"publisher","first-page":"103171","DOI":"10.1016\/j.jaut.2024.103171","article-title":"CXCL12-CXCR4 mediates CD57+ CD8+ T cell responses in the progression of type 1 diabetes","volume":"143","author":"Zhong","year":"2024","journal-title":"J. Autoimmun."},{"key":"B234","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.omto.2020.06.009","article-title":"CXCR4 antagonist AMD3100 reverses the resistance to tamoxifen in breast cancer via inhibiting AKT phosphorylation","volume":"18","author":"Zhou","year":"2020","journal-title":"Mol. Therapy-Oncolytics"},{"key":"B235","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1242\/dev.032276","article-title":"SDF1\/CXCR4 signalling regulates two distinct processes of precerebellar neuronal migration and its depletion leads to abnormal pontine nuclei formation","volume":"136","author":"Zhu","year":"2009","journal-title":"Developmen"},{"key":"B236","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/path.2350","article-title":"New insights on the role of CXCR4 in cancer metastasis","volume":"215","author":"Zlotnik","year":"2008","journal-title":"J. Pathology A J. Pathological Soc. G. B. Irel."},{"key":"B237","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/31269","article-title":"Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development","volume":"393","author":"Zou","year":"1998","journal-title":"Nature"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1410104\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T04:29:24Z","timestamp":1720758564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1410104\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":237,"alternative-id":["10.3389\/fphar.2024.1410104"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1410104","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]},"article-number":"1410104"}}